8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      The Multi-Targeting Ligand ST-2223 with Histamine H 3 Receptor and Dopamine D 2/D 3 Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Autism spectrum disorder (ASD) is a complex heterogeneous neurodevelopmental disorder characterized by social and communicative impairments, as well as repetitive and restricted behaviors (RRBs). With the limited effectiveness of current pharmacotherapies in treating repetitive behaviors, the present study determined the effects of acute systemic treatment of the novel multi-targeting ligand ST-2223, with incorporated histamine H 3 receptor (H 3R) and dopamine D 2/D 3 receptor affinity properties, on ASD-related RRBs in a male Black and Tan BRachyury (BTBR) mouse model of ASD. ST-2223 (2.5, 5, and 10 mg/kg, i.p.) significantly mitigated the increase in marble burying and self-grooming, and improved reduced spontaneous alternation in BTBR mice (all p < 0.05). Similarly, reference drugs memantine (MEM, 5 mg/kg, i.p.) and aripiprazole (ARP, 1 mg/kg, i.p.), reversed abnormally high levels of several RRBs in BTBR ( p < 0.05). Moreover, ST-2223 palliated the disturbed anxiety levels observed in an open field test (all p < 0.05), but did not restore the hyperactivity parameters, whereas MEM failed to restore mouse anxiety and hyperactivity. In addition, ST-2223 (5 mg/kg, i.p.) mitigated oxidative stress status by decreasing the elevated levels of malondialdehyde (MDA), and increasing the levels of decreased glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT) in different brain parts of treated BTBR mice (all p < 0.05). These preliminary in vivo findings demonstrate the ameliorative effects of ST-2223 on RRBs in a mouse model of ASD, suggesting its pharmacological prospective to rescue core ASD-related behaviors. Further confirmatory investigations on its effects on various brain neurotransmitters, e.g., dopamine and histamine, in different brain regions are still warranted to corroborate and expand these initial data.

          Related collections

          Most cited references106

          • Record: found
          • Abstract: not found
          • Article: not found

          A new and rapid colorimetric determination of acetylcholinesterase activity

            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Model of autism: increased ratio of excitation/inhibition in key neural systems

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.

              The open field is a very popular animal model of anxiety-like behavior. An overview of the literature on the action elicited by effective or putative anxiolytics in animal subjected to this procedure indicates that classical treatments such as benzodiazepine receptor full agonists or 5-HT(1A) receptor full or partial agonists elicit an anxiolytic-like effect in this procedure in most cases (approximately 2/3). However, compounds (triazolobenzodiazepines such as adinazolam and alprazolam, selective serotonin reuptake inhibitors) that have a different spectrum of therapeutic efficacy in anxiety disorders such as panic attacks, generalized anxiety disorder or obsessive-compulsive disorder were poorly effective as anxiolytics in the open field test, suggesting that this paradigm may not model features of anxiety disorders. The procedure is also relevant for the study of compounds endowed with anxiogenic effects, as such effects were detected after treatments with benzodiazepine receptor inverse agonists or with corticotropin releasing factor (CRF) receptor agonists.
                Bookmark

                Author and article information

                Contributors
                Role: Academic Editor
                Journal
                Int J Mol Sci
                Int J Mol Sci
                ijms
                International Journal of Molecular Sciences
                MDPI
                1422-0067
                16 February 2021
                February 2021
                : 22
                : 4
                : 1947
                Affiliations
                [1 ]Department of Pharmacology & Therapeutics, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates; 201690014@ 123456uaeu.ac.ae (N.E.); karthikkumar@ 123456uaeu.ac.ae (K.V.); petrilla.jp@ 123456uaeu.ac.ae (P.J.)
                [2 ]Zayed Center for Health Sciences, United Arab Emirates University, Al Ain P.O. Box 17666, United Arab Emirates
                [3 ]Department of Applied Sciences, College of Arts and Sciences, Abu Dhabi University, Al Ain P.O. Box 59911, United Arab Emirates
                [4 ]Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Universitaetsstr.1, 40225 Düsseldorf, Germany; mafal104@ 123456hhu.de (M.F.); mariam.dubiel@ 123456hhu.de (M.D.); a.frank@ 123456hhu.de (A.F.); David.Reiner@ 123456uni-duesseldorf.de (D.R.-L.); stark@ 123456hhu.de (H.S.)
                Author notes
                [* ]Correspondence: bassem.sadek@ 123456uaeu.ac.ae ; Tel.: +971-3-7137-512; Fax: +971-3-7672-033
                Author information
                https://orcid.org/0000-0002-1637-2699
                https://orcid.org/0000-0003-1514-2215
                https://orcid.org/0000-0003-3336-1710
                https://orcid.org/0000-0002-0320-1487
                Article
                ijms-22-01947
                10.3390/ijms22041947
                7920280
                33669336
                50f8192f-7f0e-4820-9b24-3033377f8e45
                © 2021 by the authors.

                Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( http://creativecommons.org/licenses/by/4.0/).

                History
                : 20 January 2021
                : 09 February 2021
                Categories
                Article

                Molecular biology
                autistic spectrum disorder,btbr mice,histamine h3 receptor antagonist,dopamine d2/d3r antagonist,repetitive and restricted behavior,anxiety,oxidative stress

                Comments

                Comment on this article